Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Ivor Douglas

Concepts (598)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial
24
2025
617
3.820
 Why?
Sepsis
20
2025
576
2.860
 Why?
Fluid Therapy
12
2025
133
2.490
 Why?
Respiratory Insufficiency
12
2023
313
2.330
 Why?
Critical Care
19
2025
552
2.270
 Why?
Critical Illness
20
2025
759
2.120
 Why?
Intensive Care Units
24
2025
738
2.080
 Why?
Tracheostomy
5
2024
129
1.750
 Why?
Shock, Septic
11
2024
209
1.590
 Why?
Hospital Mortality
19
2024
852
1.530
 Why?
Shock
3
2024
92
1.450
 Why?
Hospitals
6
2023
649
1.280
 Why?
Hypotension
5
2025
117
1.250
 Why?
Pneumonia
7
2023
619
1.150
 Why?
Resuscitation Orders
3
2023
43
1.020
 Why?
Resuscitation
9
2025
239
0.980
 Why?
Multiple Organ Failure
4
2024
123
0.970
 Why?
Humans
135
2025
129847
0.870
 Why?
Patient Readmission
6
2021
668
0.870
 Why?
Vasoconstrictor Agents
5
2023
127
0.860
 Why?
Ultrasonography, Doppler
1
2024
118
0.840
 Why?
Middle Aged
58
2025
31177
0.820
 Why?
Aged
45
2025
22107
0.810
 Why?
Pneumonia, Ventilator-Associated
2
2015
49
0.810
 Why?
Safety-net Providers
3
2023
110
0.750
 Why?
Hospitals, High-Volume
2
2019
39
0.740
 Why?
Hemodynamics
3
2024
1094
0.730
 Why?
Severity of Illness Index
6
2021
2739
0.720
 Why?
Monitoring, Physiologic
4
2024
266
0.710
 Why?
Extracorporeal Membrane Oxygenation
2
2023
286
0.710
 Why?
Retrospective Studies
31
2025
14553
0.700
 Why?
Patient Acceptance of Health Care
5
2021
763
0.690
 Why?
Frailty
1
2023
152
0.690
 Why?
Patient Positioning
1
2021
54
0.690
 Why?
Male
73
2025
63759
0.690
 Why?
Diabetes Insipidus
1
2020
7
0.670
 Why?
Practice Guidelines as Topic
6
2021
1514
0.650
 Why?
Substance Withdrawal Syndrome
3
2021
176
0.630
 Why?
Hospitals, Low-Volume
1
2019
22
0.620
 Why?
Noninvasive Ventilation
4
2025
49
0.600
 Why?
Dyspnea
2
2021
239
0.590
 Why?
Female
64
2025
68829
0.580
 Why?
Adult
44
2025
35634
0.560
 Why?
Delirium
3
2025
77
0.560
 Why?
Diabetes Mellitus
2
2020
1003
0.550
 Why?
Pulmonary Disease, Chronic Obstructive
8
2025
1000
0.550
 Why?
Alcoholism
5
2021
766
0.530
 Why?
Ventilator-Induced Lung Injury
3
2018
58
0.530
 Why?
Pulmonary Medicine
3
2015
80
0.520
 Why?
California
5
2022
400
0.520
 Why?
Microbiological Techniques
1
2016
30
0.510
 Why?
Sleep Medicine Specialty
1
2015
9
0.500
 Why?
Acute Lung Injury
6
2023
280
0.490
 Why?
Neoplasms
3
2023
2454
0.480
 Why?
Molecular Diagnostic Techniques
1
2016
98
0.470
 Why?
Health Policy
4
2024
354
0.470
 Why?
Hyperemia
3
2024
48
0.470
 Why?
Ethanol
2
2021
591
0.460
 Why?
Randomized Controlled Trials as Topic
10
2023
1368
0.460
 Why?
Acute Kidney Injury
7
2023
791
0.450
 Why?
Research Design
9
2023
1045
0.440
 Why?
Aged, 80 and over
13
2025
7066
0.440
 Why?
Cohort Studies
11
2023
5444
0.430
 Why?
Renin-Angiotensin System
2
2025
82
0.420
 Why?
Prone Position
3
2021
30
0.420
 Why?
Receptor, EphA2
3
2018
19
0.420
 Why?
Bronchoalveolar Lavage Fluid
2
2016
646
0.410
 Why?
Cause of Death
3
2015
395
0.410
 Why?
Laryngoscopes
2
2023
35
0.400
 Why?
Immune Tolerance
1
2015
356
0.400
 Why?
Inpatients
3
2023
477
0.400
 Why?
Nicotinic Agonists
1
2014
121
0.390
 Why?
Dual Specificity Phosphatase 1
1
2012
26
0.390
 Why?
Cross Infection
5
2020
219
0.390
 Why?
Marijuana Smoking
1
2015
247
0.380
 Why?
Hospitalization
10
2025
2079
0.380
 Why?
Apoptosis
6
2014
2489
0.370
 Why?
Lung
12
2018
3940
0.370
 Why?
Tobacco Use Disorder
1
2014
237
0.370
 Why?
Nicotine
1
2014
304
0.360
 Why?
Lipopolysaccharides
4
2017
872
0.360
 Why?
Tissue Plasminogen Activator
2
2024
222
0.360
 Why?
Organ Dysfunction Scores
2
2024
44
0.360
 Why?
Immunity, Innate
1
2017
804
0.360
 Why?
Pulmonary Fibrosis
4
2017
385
0.360
 Why?
Drug Delivery Systems
1
2014
337
0.350
 Why?
Protein C
5
2012
47
0.350
 Why?
Glycosaminoglycans
3
2016
84
0.350
 Why?
Prospective Studies
12
2024
7158
0.350
 Why?
Child Development
1
2015
459
0.340
 Why?
Long-Term Care
2
2022
92
0.330
 Why?
Emergency Service, Hospital
5
2024
1920
0.330
 Why?
Smoking Cessation
1
2014
409
0.330
 Why?
Antipsychotic Agents
2
2024
195
0.320
 Why?
Vena Cava, Inferior
3
2024
68
0.310
 Why?
Comorbidity
4
2022
1551
0.310
 Why?
Metabolic Syndrome
2
2023
340
0.310
 Why?
Public Health
1
2014
487
0.310
 Why?
Ephrin-A1
3
2018
4
0.310
 Why?
United States
18
2024
13913
0.310
 Why?
Treatment Outcome
15
2024
10241
0.310
 Why?
Length of Stay
6
2024
1133
0.310
 Why?
Cannabis
1
2015
462
0.300
 Why?
Lipid A
2
2014
29
0.300
 Why?
Institutional Practice
1
2008
3
0.300
 Why?
Intubation, Intratracheal
4
2024
248
0.290
 Why?
Societies, Medical
7
2021
759
0.290
 Why?
Odds Ratio
6
2019
1022
0.280
 Why?
Betacoronavirus
2
2020
252
0.280
 Why?
Biomarkers
7
2023
3971
0.280
 Why?
Personnel Staffing and Scheduling
1
2008
89
0.280
 Why?
Pandemics
4
2024
1500
0.280
 Why?
Neutrophils
3
2024
1209
0.270
 Why?
Anti-Bacterial Agents
1
2017
1708
0.270
 Why?
Pulmonary Alveolar Proteinosis
1
2007
17
0.270
 Why?
Integrins
1
2007
94
0.270
 Why?
Neovascularization, Pathologic
2
2007
297
0.270
 Why?
Haloperidol
3
2025
32
0.260
 Why?
Patient Admission
2
2023
183
0.260
 Why?
MAP Kinase Signaling System
2
2014
314
0.260
 Why?
Hyponatremia
1
2006
40
0.260
 Why?
Lung Injury
3
2016
211
0.250
 Why?
Renal Insufficiency, Chronic
2
2024
567
0.250
 Why?
Lung Diseases, Obstructive
1
2006
46
0.250
 Why?
Ultrasonography
3
2024
713
0.250
 Why?
Leukocytes
1
2007
306
0.250
 Why?
Double-Blind Method
9
2024
1877
0.250
 Why?
Pneumonia, Viral
2
2020
342
0.250
 Why?
Coronavirus Infections
2
2020
336
0.240
 Why?
Medicaid
3
2021
433
0.240
 Why?
Laryngoscopy
2
2023
100
0.240
 Why?
Biomedical Research
3
2021
640
0.240
 Why?
Chemokines, CXC
1
2005
70
0.240
 Why?
Academic Medical Centers
3
2021
483
0.240
 Why?
Bronchi
1
2006
249
0.240
 Why?
Regeneration
1
2006
182
0.230
 Why?
Oxazines
1
2024
28
0.230
 Why?
Bronchiectasis
1
2006
110
0.230
 Why?
Bronchiolitis Obliterans
1
2005
68
0.230
 Why?
Adrenal Insufficiency
2
2013
32
0.230
 Why?
Infusions, Intravenous
5
2024
402
0.230
 Why?
Methylprednisolone
1
2005
83
0.230
 Why?
Phagocytosis
1
2006
362
0.220
 Why?
Venous Pressure
1
2024
8
0.220
 Why?
Patient Protection and Affordable Care Act
2
2016
101
0.220
 Why?
Plasminogen
1
2024
30
0.220
 Why?
Morpholines
1
2024
123
0.220
 Why?
Leukocyte Elastase
1
2024
77
0.220
 Why?
Respiratory Mucosa
1
2006
310
0.220
 Why?
Vasopressins
3
2021
64
0.220
 Why?
Plasminogen Activator Inhibitor 1
1
2024
84
0.220
 Why?
Anti-Infective Agents
4
2012
249
0.220
 Why?
Cytokines
7
2017
2022
0.210
 Why?
beta Catenin
1
2005
224
0.210
 Why?
Atrial Pressure
1
2023
3
0.210
 Why?
Renal Dialysis
4
2023
423
0.210
 Why?
Hypoxia
3
2024
1087
0.210
 Why?
Receptor, Angiotensin, Type 1
1
2023
22
0.210
 Why?
Diterpenes
2
2014
31
0.210
 Why?
Risk Factors
10
2021
9801
0.210
 Why?
Area Under Curve
3
2020
306
0.210
 Why?
Craniocerebral Trauma
1
2005
151
0.200
 Why?
Analgesics, Non-Narcotic
1
2024
122
0.200
 Why?
Lung Diseases
3
2016
743
0.200
 Why?
Hemodynamic Monitoring
1
2022
1
0.200
 Why?
Fibrinolysis
1
2024
137
0.200
 Why?
Thiazoles
2
2024
118
0.200
 Why?
Fibrosis
1
2005
526
0.200
 Why?
Treatment Failure
6
2021
339
0.190
 Why?
Evidence-Based Medicine
5
2016
716
0.190
 Why?
Early Diagnosis
4
2017
233
0.190
 Why?
Acetaminophen
1
2024
248
0.190
 Why?
Transportation
1
2022
50
0.190
 Why?
Clinical Decision-Making
1
2024
304
0.180
 Why?
Logistic Models
7
2017
1989
0.180
 Why?
Vasodilator Agents
1
2023
326
0.180
 Why?
Hydrocortisone
1
2003
306
0.180
 Why?
Pyridines
1
2024
478
0.180
 Why?
Central Nervous System Depressants
1
2021
83
0.180
 Why?
Receptors, Interleukin-6
1
2021
37
0.180
 Why?
Heart Arrest
2
2021
323
0.180
 Why?
Stroke Volume
1
2024
593
0.170
 Why?
Hospital Charges
1
2020
42
0.170
 Why?
Piperazines
2
2024
339
0.170
 Why?
Health Priorities
1
2020
34
0.170
 Why?
Rib Fractures
1
2020
32
0.170
 Why?
Hydroxychloroquine
1
2020
55
0.170
 Why?
Glucocorticoids
1
2005
582
0.170
 Why?
Community-Acquired Infections
3
2020
160
0.170
 Why?
Internship and Residency
2
2019
1058
0.170
 Why?
Reproducibility of Results
5
2024
3089
0.170
 Why?
Antigens, Differentiation
1
2000
82
0.170
 Why?
Animals
20
2018
35409
0.160
 Why?
Heart Failure
3
2023
2148
0.160
 Why?
Patient Selection
1
2023
660
0.160
 Why?
Cell Proliferation
2
2014
2378
0.160
 Why?
Patient Handoff
1
2019
32
0.160
 Why?
Risk Adjustment
1
2020
79
0.160
 Why?
Cell Adhesion Molecules
1
2000
173
0.150
 Why?
Hospital Costs
1
2019
115
0.150
 Why?
Dopamine Antagonists
1
2018
23
0.150
 Why?
Mice, Inbred C57BL
9
2018
5468
0.150
 Why?
Combined Modality Therapy
2
2020
1201
0.150
 Why?
Age Factors
4
2019
3161
0.150
 Why?
ROC Curve
1
2020
504
0.150
 Why?
Blood Glucose Self-Monitoring
1
2023
601
0.150
 Why?
Orthopedic Procedures
1
2020
209
0.150
 Why?
Antimicrobial Stewardship
1
2020
107
0.140
 Why?
Thrombosis
1
2021
349
0.140
 Why?
Caregivers
1
2025
809
0.140
 Why?
Health Services Accessibility
4
2020
903
0.140
 Why?
Optometry
1
2017
5
0.140
 Why?
Eosinophils
1
2000
324
0.140
 Why?
Platelet Count
2
2014
82
0.140
 Why?
Guideline Adherence
2
2014
527
0.140
 Why?
Cell Adhesion
4
2012
455
0.140
 Why?
Tidal Volume
2
2014
85
0.140
 Why?
Predictive Value of Tests
4
2016
1951
0.140
 Why?
Blood Glucose
2
2023
2103
0.140
 Why?
Lymphocyte Count
1
2017
148
0.130
 Why?
Analysis of Variance
1
2020
1291
0.130
 Why?
Transients and Migrants
1
2017
26
0.130
 Why?
Pyrimidines
2
2024
458
0.130
 Why?
Tretinoin
1
2017
121
0.130
 Why?
Mice
13
2017
16983
0.130
 Why?
Nephrectomy
2
2008
158
0.130
 Why?
Cystic Fibrosis
1
2006
1067
0.130
 Why?
Health Insurance Exchanges
1
2016
1
0.130
 Why?
Delivery of Health Care
1
2023
900
0.130
 Why?
Continuity of Patient Care
1
2018
277
0.130
 Why?
Clinical Trials as Topic
1
2021
1005
0.130
 Why?
Attitude of Health Personnel
3
2019
1106
0.130
 Why?
Risk Management
1
2017
92
0.130
 Why?
Ventricular Function, Right
1
2018
276
0.130
 Why?
Sleep Wake Disorders
2
2017
255
0.130
 Why?
Breath Tests
1
2016
87
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2021
756
0.120
 Why?
Ventricular Dysfunction, Right
1
2018
231
0.120
 Why?
Burnout, Professional
1
2021
411
0.120
 Why?
Respiratory Tract Diseases
1
2017
149
0.120
 Why?
Research
1
2018
420
0.120
 Why?
Survival Analysis
4
2014
1271
0.120
 Why?
Alcohol Withdrawal Seizures
1
2014
1
0.120
 Why?
Staphylococcus aureus
2
2011
436
0.120
 Why?
Alcohol Withdrawal Delirium
1
2014
8
0.120
 Why?
Automation
1
2015
81
0.120
 Why?
Bronchoalveolar Lavage
1
2015
92
0.120
 Why?
Marriage
1
2016
116
0.120
 Why?
5-Lipoxygenase-Activating Protein Inhibitors
1
2014
1
0.110
 Why?
5-Lipoxygenase-Activating Proteins
1
2014
4
0.110
 Why?
Prognosis
5
2021
3773
0.110
 Why?
Bacteriological Techniques
1
2015
70
0.110
 Why?
Multicenter Studies as Topic
3
2023
287
0.110
 Why?
Risk Assessment
5
2015
3269
0.110
 Why?
Patient Care Team
1
2019
603
0.110
 Why?
Fluorobenzenes
1
2014
15
0.110
 Why?
Leukotrienes
1
2014
37
0.110
 Why?
Phenanthrenes
1
2014
12
0.110
 Why?
Quality of Life
2
2024
2695
0.110
 Why?
Physicians
2
2021
875
0.110
 Why?
APACHE
2
2011
65
0.110
 Why?
Down-Regulation
2
2017
631
0.110
 Why?
Catheterization, Central Venous
1
2015
104
0.110
 Why?
Potassium
1
2014
144
0.110
 Why?
Education, Medical
1
2017
254
0.110
 Why?
Alanine Transaminase
1
2014
154
0.110
 Why?
Poverty
2
2016
499
0.110
 Why?
Systemic Inflammatory Response Syndrome
1
2014
85
0.110
 Why?
CD4-Positive T-Lymphocytes
1
2000
1058
0.110
 Why?
Kaplan-Meier Estimate
5
2018
851
0.110
 Why?
Laryngeal Masks
1
2013
11
0.110
 Why?
Microscopy
1
2015
140
0.110
 Why?
Quinolines
1
2014
156
0.100
 Why?
Time Factors
7
2023
6550
0.100
 Why?
Health Knowledge, Attitudes, Practice
2
2024
1284
0.100
 Why?
Glycocalyx
1
2012
22
0.100
 Why?
Sensitivity and Specificity
2
2015
1847
0.100
 Why?
Patient Discharge
1
2018
856
0.100
 Why?
Patient-Centered Care
1
2017
508
0.100
 Why?
Physician-Patient Relations
1
2017
542
0.100
 Why?
Acute Disease
3
2016
980
0.100
 Why?
Supine Position
1
2012
38
0.100
 Why?
Cisplatin
1
2014
299
0.100
 Why?
Biomarkers, Pharmacological
1
2012
26
0.100
 Why?
Data Interpretation, Statistical
2
2011
338
0.100
 Why?
Oxygen
3
2023
916
0.100
 Why?
I-kappa B Proteins
1
2012
79
0.090
 Why?
Clinical Alarms
1
2011
10
0.090
 Why?
Insurance, Health
1
2014
269
0.090
 Why?
Data Display
1
2011
20
0.090
 Why?
Health Status
1
2017
758
0.090
 Why?
Follow-Up Studies
5
2024
4896
0.090
 Why?
Endotoxemia
1
2012
85
0.090
 Why?
Adrenergic beta-2 Receptor Agonists
1
2011
36
0.090
 Why?
Indoles
1
2014
387
0.090
 Why?
Albuterol
1
2011
105
0.090
 Why?
Genetic Markers
1
2012
334
0.090
 Why?
Sulfonamides
1
2014
497
0.080
 Why?
Fibrinolytic Agents
2
2024
262
0.080
 Why?
Alcohol-Related Disorders
1
2011
118
0.080
 Why?
Peroxidase
2
2008
175
0.080
 Why?
Stenotrophomonas maltophilia
1
2009
2
0.080
 Why?
Recombinant Proteins
5
2012
1311
0.080
 Why?
Interferons
1
2011
189
0.080
 Why?
Thoracic Diseases
1
2009
14
0.080
 Why?
Clinical Protocols
2
2012
254
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
430
0.080
 Why?
Decision Making
1
2017
864
0.080
 Why?
Survival Rate
3
2015
1872
0.080
 Why?
Wounds and Injuries
1
2016
711
0.080
 Why?
Ligands
2
2023
621
0.080
 Why?
Symptom Assessment
2
2020
125
0.080
 Why?
Gram-Negative Bacterial Infections
1
2009
45
0.080
 Why?
Adrenal Cortex Hormones
1
2013
532
0.080
 Why?
Blotting, Western
1
2012
1204
0.080
 Why?
Cell Movement
3
2011
950
0.080
 Why?
Databases, Factual
2
2016
1269
0.080
 Why?
Polymerase Chain Reaction
1
2012
1033
0.080
 Why?
Disease Models, Animal
5
2018
4077
0.080
 Why?
Confidence Intervals
1
2010
318
0.080
 Why?
Up-Regulation
1
2012
836
0.080
 Why?
Age Distribution
1
2010
372
0.080
 Why?
Cues
1
2011
329
0.080
 Why?
Sex Distribution
1
2010
359
0.080
 Why?
Pancreatitis
1
2009
129
0.070
 Why?
Pneumonia, Bacterial
1
2009
115
0.070
 Why?
Pulmonary Alveoli
2
2012
403
0.070
 Why?
Work Schedule Tolerance
1
2008
43
0.070
 Why?
Models, Statistical
1
2012
624
0.070
 Why?
Clinical Trials, Phase III as Topic
2
2023
94
0.070
 Why?
Healthcare Disparities
1
2014
580
0.070
 Why?
Incidence
1
2014
2646
0.070
 Why?
United Kingdom
1
2008
258
0.070
 Why?
Interleukin-6
2
2008
724
0.070
 Why?
Pulmonary Emphysema
2
2007
275
0.070
 Why?
Flavonoids
1
2007
76
0.070
 Why?
Mandatory Programs
1
2007
15
0.070
 Why?
Child, Preschool
2
2015
10522
0.070
 Why?
Clinical Competence
1
2014
1020
0.070
 Why?
Demeclocycline
1
2006
3
0.070
 Why?
Disease Progression
4
2017
2628
0.070
 Why?
Mice, Inbred C3H
1
2007
271
0.070
 Why?
Lithium Compounds
1
2006
11
0.070
 Why?
Methicillin Resistance
1
2006
18
0.070
 Why?
Workload
1
2008
153
0.070
 Why?
Signal Transduction
4
2018
4935
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
151
0.070
 Why?
Rats, Sprague-Dawley
1
2012
2403
0.070
 Why?
Carcinoma, Non-Small-Cell Lung
1
1995
1050
0.060
 Why?
Mitogen-Activated Protein Kinase 1
1
2007
184
0.060
 Why?
Intercellular Adhesion Molecule-1
2
2012
135
0.060
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
100
0.060
 Why?
Diuretics
1
2006
76
0.060
 Why?
Hospitals, Urban
2
2018
135
0.060
 Why?
Mesoderm
1
2007
138
0.060
 Why?
Hospital Information Systems
1
2006
14
0.060
 Why?
Sex Factors
3
2018
1973
0.060
 Why?
History, 20th Century
2
2017
295
0.060
 Why?
Adolescent
5
2025
20451
0.060
 Why?
Radiography, Thoracic
1
2007
165
0.060
 Why?
Asparagine
1
2005
30
0.060
 Why?
Butylated Hydroxytoluene
1
2005
38
0.060
 Why?
Mice, Inbred BALB C
2
2005
1248
0.060
 Why?
Protein Kinase Inhibitors
2
2024
886
0.060
 Why?
Rats
2
2012
5487
0.060
 Why?
Vocabulary
1
2006
46
0.060
 Why?
Cyclin D1
1
2005
62
0.060
 Why?
Emphysema
1
2006
109
0.060
 Why?
Bronchoscopy
1
2007
219
0.060
 Why?
Heparin
1
2007
254
0.060
 Why?
Cell Line, Transformed
1
2005
139
0.060
 Why?
Young Adult
5
2025
12467
0.060
 Why?
Occupational Health
1
2008
193
0.060
 Why?
Medical Order Entry Systems
1
2006
44
0.060
 Why?
Caspase Inhibitors
1
2005
81
0.060
 Why?
Blood Vessels
1
2007
187
0.060
 Why?
Hypertension, Pulmonary
2
2007
1897
0.060
 Why?
Gene Expression Regulation
2
2012
2545
0.060
 Why?
Angiotensin I
1
2025
7
0.060
 Why?
Venous Thrombosis
1
2007
176
0.060
 Why?
Gene Expression Profiling
1
2012
1686
0.060
 Why?
Ischemia
1
2008
405
0.060
 Why?
Neuromuscular Nondepolarizing Agents
1
2024
17
0.060
 Why?
Necrosis
1
2005
234
0.060
 Why?
Androstanols
1
2024
17
0.060
 Why?
HMGB1 Protein
1
2005
49
0.060
 Why?
Caspases
1
2005
245
0.060
 Why?
Pyridazines
1
2024
54
0.060
 Why?
Hope
1
2024
22
0.060
 Why?
Macrophages
2
2014
1489
0.060
 Why?
Colorado
4
2017
4410
0.060
 Why?
Diabetic Ketoacidosis
1
2007
197
0.060
 Why?
T-Lymphocyte Subsets
1
2006
412
0.060
 Why?
Medicago
1
2023
1
0.060
 Why?
Cadherins
1
2005
190
0.050
 Why?
Renal Replacement Therapy
1
2024
87
0.050
 Why?
Steroids
2
2021
158
0.050
 Why?
Practice Patterns, Physicians'
3
2024
1274
0.050
 Why?
Uncertainty
1
2024
122
0.050
 Why?
Enzyme Inhibitors
1
2007
827
0.050
 Why?
Atrial Function, Right
1
2023
12
0.050
 Why?
Angiotensins
1
2023
9
0.050
 Why?
Multivariate Analysis
2
2017
1501
0.050
 Why?
Collagen
1
2005
438
0.050
 Why?
Heparitin Sulfate
2
2014
42
0.050
 Why?
Mental Health
2
2022
691
0.050
 Why?
Biopsy
1
2007
1089
0.050
 Why?
Drug Administration Schedule
2
2018
766
0.050
 Why?
Inflammatory Bowel Diseases
1
2007
326
0.050
 Why?
Antineoplastic Agents
1
2014
2045
0.050
 Why?
Homeostasis
1
2006
605
0.050
 Why?
Autoimmune Diseases
1
2006
428
0.050
 Why?
Angiotensin II
1
2023
95
0.050
 Why?
Decision Support Techniques
2
2020
401
0.050
 Why?
Anticoagulants
1
2007
637
0.050
 Why?
Diagnosis, Differential
1
2007
1434
0.050
 Why?
Video Recording
1
2023
164
0.050
 Why?
Lung Neoplasms
1
1995
2344
0.050
 Why?
Hemoglobins
1
2024
339
0.050
 Why?
Child
2
2015
20962
0.050
 Why?
Staphylococcal Infections
1
2006
391
0.050
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
277
0.050
 Why?
Partial Thromboplastin Time
1
2021
52
0.050
 Why?
Creatinine
2
2015
490
0.050
 Why?
Endothelial Cells
1
2007
749
0.050
 Why?
Infant
1
2015
9018
0.050
 Why?
Oligopeptides
1
2023
260
0.050
 Why?
Electrocardiography
1
2024
613
0.040
 Why?
Antibodies
2
2018
399
0.040
 Why?
Perioperative Care
1
2022
166
0.040
 Why?
Peptide Fragments
1
2025
695
0.040
 Why?
Lung Diseases, Interstitial
1
2007
611
0.040
 Why?
Leukotriene C4
1
2000
11
0.040
 Why?
Hemorrhage
1
2005
680
0.040
 Why?
CD18 Antigens
1
2000
26
0.040
 Why?
N-Formylmethionine Leucyl-Phenylalanine
1
2000
56
0.040
 Why?
Drug Resistance, Microbial
1
2020
69
0.040
 Why?
Chronic Disease
1
2006
1724
0.040
 Why?
CD11 Antigens
1
2000
30
0.040
 Why?
Glasgow Coma Scale
1
2020
165
0.040
 Why?
Costs and Cost Analysis
1
2020
201
0.040
 Why?
Epithelial Cells
1
2005
1063
0.040
 Why?
Needs Assessment
1
2021
357
0.040
 Why?
Hospitals, University
1
2019
180
0.040
 Why?
Smoking
1
2006
1502
0.040
 Why?
Flow Cytometry
2
2017
1160
0.040
 Why?
Aftercare
1
2001
206
0.040
 Why?
Oxidative Stress
1
2005
1264
0.040
 Why?
NF-kappa B
2
2018
666
0.040
 Why?
Algorithms
1
2006
1617
0.040
 Why?
Infection Control
1
2020
143
0.040
 Why?
Surveys and Questionnaires
3
2021
5437
0.040
 Why?
Adjuvants, Immunologic
1
2000
222
0.040
 Why?
Injury Severity Score
1
2020
509
0.040
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2018
4
0.040
 Why?
Linear Models
1
2020
822
0.040
 Why?
Mice, Knockout
3
2012
2888
0.040
 Why?
T-Lymphocytes
1
2006
1937
0.040
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
38
0.040
 Why?
Trauma Centers
1
2020
402
0.040
 Why?
Victoria
1
2017
16
0.040
 Why?
Mortality
1
2019
308
0.030
 Why?
Family
1
2022
646
0.030
 Why?
Antigens, CD
1
2000
487
0.030
 Why?
History, 17th Century
1
2017
14
0.030
 Why?
History, 15th Century
1
2017
11
0.030
 Why?
History, 16th Century
1
2017
15
0.030
 Why?
United Arab Emirates
1
2017
7
0.030
 Why?
History, Ancient
1
2017
52
0.030
 Why?
History, Medieval
1
2017
44
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2025
813
0.030
 Why?
Recovery of Function
1
2021
645
0.030
 Why?
Drug Therapy, Combination
2
2012
1042
0.030
 Why?
Critical Care Outcomes
1
2016
12
0.030
 Why?
History, 21st Century
1
2017
186
0.030
 Why?
Cross-Sectional Studies
2
2021
5085
0.030
 Why?
Trauma Severity Indices
1
2016
105
0.030
 Why?
Probability
1
2017
304
0.030
 Why?
Lymphocyte Activation
1
2000
1110
0.030
 Why?
Refugees
1
2017
68
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2018
434
0.030
 Why?
Uteroglobin
1
2014
23
0.030
 Why?
Anxiety
1
2022
976
0.030
 Why?
Chemokine CXCL2
1
2014
43
0.030
 Why?
Cost-Benefit Analysis
1
2017
569
0.030
 Why?
Arachidonate 5-Lipoxygenase
1
2014
42
0.030
 Why?
Pilot Projects
1
2019
1597
0.030
 Why?
Rosuvastatin Calcium
1
2014
20
0.030
 Why?
Nitrites
1
2014
83
0.030
 Why?
MAP Kinase Kinase 4
1
2014
28
0.030
 Why?
Risk
1
2017
860
0.030
 Why?
Socioeconomic Factors
1
2018
1214
0.030
 Why?
Creatine Kinase
1
2014
75
0.030
 Why?
Epoxy Compounds
1
2014
33
0.030
 Why?
Nitrates
1
2014
88
0.030
 Why?
Quality Indicators, Health Care
1
2017
298
0.030
 Why?
Chondroitin Sulfates
1
2014
35
0.030
 Why?
Toll-Like Receptor 2
1
2014
113
0.030
 Why?
Kidney Function Tests
1
2014
152
0.030
 Why?
Leukocyte Count
1
2014
326
0.030
 Why?
Manikins
1
2013
26
0.030
 Why?
Liver Failure
1
2014
91
0.030
 Why?
Bronchial Spasm
1
2013
6
0.030
 Why?
Cryptogenic Organizing Pneumonia
1
2013
19
0.030
 Why?
Contraindications
1
2013
90
0.030
 Why?
Chromatography, Liquid
1
2015
426
0.030
 Why?
Quality Improvement
1
2021
1112
0.030
 Why?
Mass Spectrometry
1
2016
717
0.030
 Why?
Depression
1
2022
1323
0.020
 Why?
Glucuronidase
1
2012
44
0.020
 Why?
Protein C Deficiency
1
2012
8
0.020
 Why?
Connective Tissue Diseases
1
2013
82
0.020
 Why?
Anesthesiology
1
2013
63
0.020
 Why?
Cells, Cultured
1
2000
4102
0.020
 Why?
Knowledge Bases
1
2012
24
0.020
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
86
0.020
 Why?
Toll-Like Receptor 4
1
2014
264
0.020
 Why?
Intestinal Perforation
1
2012
45
0.020
 Why?
Triage
1
2014
207
0.020
 Why?
Renal Insufficiency
1
2014
149
0.020
 Why?
Tandem Mass Spectrometry
1
2015
528
0.020
 Why?
Quality of Health Care
1
2017
610
0.020
 Why?
Disease Management
1
2016
592
0.020
 Why?
Quality Assurance, Health Care
1
2014
318
0.020
 Why?
Endothelium
1
2012
121
0.020
 Why?
Water-Electrolyte Balance
1
2011
34
0.020
 Why?
Adoptive Transfer
1
2012
218
0.020
 Why?
Epistasis, Genetic
1
2012
70
0.020
 Why?
General Surgery
1
2013
152
0.020
 Why?
Cross-Over Studies
1
2013
521
0.020
 Why?
Cell Survival
1
2014
1086
0.020
 Why?
Microbial Viability
1
2011
83
0.020
 Why?
Superoxides
1
2011
201
0.020
 Why?
Internal Medicine
1
2013
247
0.020
 Why?
Enzyme Activation
1
2012
813
0.020
 Why?
Viruses
1
2011
100
0.020
 Why?
Interleukin-8
1
2011
264
0.020
 Why?
Cell Separation
1
2011
316
0.020
 Why?
Longitudinal Studies
1
2017
2724
0.020
 Why?
Single-Payer System
1
2009
2
0.020
 Why?
Species Specificity
1
2011
568
0.020
 Why?
Arthroplasty, Replacement, Knee
1
2014
306
0.020
 Why?
Disease-Free Survival
1
2011
647
0.020
 Why?
Cell Death
1
2011
353
0.020
 Why?
Administration, Inhalation
1
2011
673
0.020
 Why?
Survivors
1
2013
464
0.020
 Why?
Nitric Oxide
1
2014
896
0.020
 Why?
Information Dissemination
1
2011
206
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2011
836
0.020
 Why?
Advisory Committees
1
2010
216
0.020
 Why?
Case-Control Studies
1
2016
3384
0.020
 Why?
Self Report
1
2013
800
0.020
 Why?
Drug Resistance, Bacterial
1
2009
175
0.020
 Why?
Cell Line
1
2014
2780
0.020
 Why?
Total Quality Management
1
2008
60
0.020
 Why?
Ventilator Weaning
1
2008
36
0.020
 Why?
Precision Medicine
1
2012
385
0.020
 Why?
Microbial Sensitivity Tests
1
2009
349
0.020
 Why?
Placebos
1
2008
201
0.020
 Why?
Neutrophil Infiltration
1
2008
105
0.020
 Why?
Capillary Permeability
1
2008
141
0.020
 Why?
United States Food and Drug Administration
1
2008
205
0.020
 Why?
Health Plan Implementation
1
2008
137
0.020
 Why?
Interdisciplinary Communication
1
2008
187
0.020
 Why?
Drug Industry
1
2008
106
0.020
 Why?
Chemokines
1
2008
227
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2012
1205
0.020
 Why?
Acid-Base Equilibrium
1
2007
27
0.020
 Why?
Dose-Response Relationship, Drug
1
2011
2016
0.020
 Why?
Cost Control
1
2006
39
0.020
 Why?
Umbilical Veins
1
2006
61
0.020
 Why?
Medical Audit
1
2007
74
0.020
 Why?
CD8 Antigens
1
2006
75
0.020
 Why?
Ketones
1
2007
48
0.020
 Why?
Microcirculation
1
2007
145
0.020
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2006
107
0.020
 Why?
CD4 Antigens
1
2006
137
0.020
 Why?
Bacillus subtilis
1
2006
65
0.020
 Why?
Information Management
1
2006
17
0.020
 Why?
Cell Count
1
2006
318
0.020
 Why?
Fluorescent Antibody Technique
1
2006
377
0.020
 Why?
Genome-Wide Association Study
1
2012
1326
0.010
 Why?
User-Computer Interface
1
2006
149
0.010
 Why?
Interleukin-10
1
2006
304
0.010
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
253
0.010
 Why?
Polymorphism, Single Nucleotide
1
2012
2062
0.010
 Why?
Inflammation Mediators
1
2006
505
0.010
 Why?
Asthma
1
2017
2225
0.010
 Why?
Hypoglycemia
1
2007
427
0.010
 Why?
Endothelium, Vascular
1
2007
902
0.010
 Why?
Cardiotonic Agents
1
2001
126
0.010
 Why?
Hypothermia, Induced
1
2001
76
0.010
 Why?
RNA, Messenger
1
2006
2703
0.010
 Why?
Mass Screening
1
2006
1192
0.010
 Why?
Dopamine
1
2001
286
0.010
 Why?
Hypoglycemic Agents
1
2007
1221
0.010
 Why?
Anti-Inflammatory Agents
1
2001
482
0.010
 Why?
Insulin
1
2007
2330
0.010
 Why?
Douglas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (598) concept(s)
_
Co-Authors Expand Description
See all (77) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)